A recent study demonstrated that the deletion of LSD1 leads to a reduction in exosomal PD-L1 levels and restores T-cell response in GC [28], which suggests that targeting LSD1 could be a promising strategy to inhibit the growth of GC. Here, KDM1A is linked to gastric cancer.